Publications: Dr Samar Mohamed Ibrahim Elorbany
Elorbany S, Berlato C, Carnevalli LS, Maniati E, Barry ST, Wang J, Manchanda R, Kzhyshkowska J et al.
(
2024
)
.
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
.
Nature Communications
vol.
15
,
(
1
)
Berlato C, Heath O, Maniati E, Gopinathan G, Kotantaki P, Elorbany S, McDermott J, Pegrum C et al.
(
2021
)
.
Abstract 2745: Murine high grade serous ovarian cancer (HGSOC) models replicate the human tumor microenvironment and suggest anti-tumor activities of macrophages after chemotherapy
.
Cancer Research
.
vol.
81
,
2745
-
2745
.
Heath O, Berlato C, Maniati E, Lakhani A, Pegrum C, Kotantaki P, Elorbany S, Böhm S et al.
(
2021
)
.
Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer
.
Cancer Immunology Research
vol.
9
,
(
6
)
665
-
681
.
Berlato C, Heath O, Maniati E, Gopinathan G, Kotantaki P, Elorbany S, McDermott J, Pegrum C et al.
(
2021
)
.
Murine high grade serous ovarian cancer (HGSOC) models replicate the human tumor microenvironment and suggest anti-tumor activities of macrophages after chemotherapy
.
CANCER RESEARCH
.
vol.
81
,